Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

A multicenter retrospective study was conducted to evaluate the efficacy and safety of cabozantinib in patients with advanced or metastatic renal cell carcinoma (mRCC). We enrolled 53 patients with mRCC who received cabozantinib at eight institutions in Japan. The primary endpoint was overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Iinuma, Koji, Tomioka-Inagawa, Risa, Kameyama, Koji, Taniguchi, Tomoki, Kawada, Kei, Ishida, Takashi, Nagai, Shingo, Enomoto, Torai, Ueda, Shota, Kawase, Makoto, Takeuchi, Shinichi, Kawase, Kota, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775439/
https://www.ncbi.nlm.nih.gov/pubmed/36551927
http://dx.doi.org/10.3390/biomedicines10123172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775439/
https://www.ncbi.nlm.nih.gov/pubmed/36551927
http://dx.doi.org/10.3390/biomedicines10123172

Ejemplares similares